Reported Earlier, ADARx Pharmaceuticals Prices Upsized Initial Public Offering Of 26,250,000 Common Shares At $17.00 Per Share, Raising $446.3M
Share
Why It Matters
ADARx just sold new shares to raise money for its business. When a company does this, watch whether the stock stays steady or moves around.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.